Pet Industry News
The deals, launches, and strategic moves behind the brands and operators shaping the industry.
Escalade Buys ASL Solutions, Betting on Pet Hard Goods
Escalade, the public sporting goods company behind Goalrilla and STIGA, has acquired ASL Solutions, a founder-owned manufacturer of insulated dog and cat houses. The deal, terms undisclosed, hands Escalade a rotational molding capability it didn't have before and marks its first move into pet hard goods.
Gallant Posts Pilot Data on IV Stem Cell Therapy for Canine OA, Wins Expanded FDA Conditional Approval Eligibility
Pilot data from Gallant on its IV-delivered stem cell therapy for canine osteoarthritis showed statistically significant improvement, and the company won expanded FDA conditional approval eligibility targeting 2028. Pet pharma just entered its biotech era.
Spectrum Brands Pet Care Sales Up 11% as Aquatics Aisle Returns to Growth
Q2 fiscal 2026 results from Spectrum Brands beat consensus, with Global Pet Care up 11.2% reported and 7.6% organic to $299.3 million. The print confirms the aquatics aisle and grooming-tools categories have bottomed.
Phibro Q3 Sales Up 10% as MFA Acquisition Pays Off; VERRATAIN Sustainability Platform Launches
Q3 fiscal 2026 net sales at Phibro were $383.5M, up 10%, with raised guidance. The company also launched VERRATAIN, a sustainability platform that positions Phibro at a new layer of the pet food and animal protein supply chain.
Central Garden & Pet Posts Record Q2, EPS Up 31%
Record Q2 at Central Garden & Pet: net sales $906M (up 9%), EPS $1.28 (up 31%), gross margin up 30 bps. Pet consumables demand has decoupled from the cooling therapeutics market.
Freshpet Q1 Posts $48.5M Profit and Plans to Triple Tractor Supply Footprint
Q1 net sales at Freshpet grew 13.1% to $297.6 million and the company swung to a $48.5 million profit. The more consequential news was the plan to expand fresh and frozen pet food to roughly 700 Tractor Supply stores by year-end, up from 80.
Elanco Posts 10% Organic Growth and Becomes the #2 Stealing Share
Q1 2026 organic revenue at Elanco grew 10%, the company beat consensus, and management raised full-year guidance. Credelio Quattro and Zenrelia are gaining share in dermatology and parasiticides — companion animal therapeutics is now a contested category.